HOW TO BUY ALLOVIR STOCK: REVOLUTIONIZING CELL THERAPIES

Listed at the NASDAQ Exchange (Stock Symbol: ALVR)

How to Open a Trading Account to Invest in How to Buy AlloVir Shares

Opening an investment account with an Online Broker is a process that is completed online and requires:

1. First, choose the broker that best fits you. Here, we present eToro as the primary choice.

2. Upload an ID and a proof of address (electricity, water bills, etc.) through the Broker's App or via email.

3. Whether you open it with eToro or with another broker, make sure to choose the correct base currency of the account. With some brokers, changing it once you open the account can be painful. Trading Accounts are available on US Dollars (USD), Euros (EUR), Pound Sterling (GBP), Swiss Franc (CHF), Australian Dollar (AUD) as the base currency. Practically all of them offer the option in US Dollars or Euros.

4. Once the Broker has approved the account, it's time to deposit cash. The depositing and withdrawing money methods are usually Credit Cards, Bank Transfers or eWallets (PayPal, PaySafe, Skrill, SafetyPay, Neteller, among others). The available options to deposit funds will depend on each Broker. A vital fact to mention is that all of the Brokers presented above allow you to use a simulator on their platform; that is, they allow testing their Demo account, which is Free. In other words, you can open a Demo account, try the platform, and then decide whether to deposit money or not.

5. Upon the capital is credited into your credited account, you may now buy the Stock.

Is it easy to invest in AlloVir Shares?

Online Brokers allow investing in Shares straightforwardly through optimised apps that grant easy and fast access to financial markets. Most platforms resemble a social network or any other phone app: They are designed so that the investor can learn and start trading very quickly, without the need for much prior knowledge. To buy shares of AlloVir, you have to:

1. open a trading account as explained before,

2. deposit money,

3. Search for "AlloVir" on the Broker's Trading platform, and

4. press the "Buy" button.

And, done, you are officially investing in the co's shares.

About AlloVir

AlloVir is an American healthcare company and is one of the leading names around the globe in the development of Virus-Specific T-cell (VST) immunotherapies. Founded in 2013 and headquartered in Cambridge, Massachusetts, the firm is focused on developing highly innovative, allogeneic, off-the-shelf VST therapy candidates which target twelve devastating viral infections with both treatment and prevention. The firm’s work aims at helping patients with T-cell deficiencies, many of whom currently have limited treatment options or no viable treatment at all.

The company launched publicly in 2020 with an upsized IPO that raised $276.25m. Allovir is listed on the NASDAQ GS and trades its stock under the ticker ALVR. In November 2020, the ALVR share price was $34.55, and the company had a market cap of $2.13bn.

The company’s platform is highly efficient, practising advanced VST profiling and antigen selection to induce the most robust T-cell immune responses. Their CytokinTM donor selection process ensures an efficient selection of carefully screened donors. The firm maintains a pipeline of therapeutic candidates in pre-clinical and clinical trials targeting high-risk individuals, such as organ transplant patients and those suffering various chronic illnesses.